Next Article in Journal
Contribution of Anoctamins to Cell Survival and Cell Death
Next Article in Special Issue
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis
Previous Article in Journal
Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets
Previous Article in Special Issue
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
 
 
Review

Article Versions Notes

Cancers 2019, 11(3), 381; https://doi.org/10.3390/cancers11030381
Action Date Notes Link
article xml file uploaded 18 March 2019 15:11 CET Original file -
article pdf uploaded. 18 March 2019 15:11 CET Version of Record https://www.mdpi.com/2072-6694/11/3/381/pdf-vor
article xml file uploaded 26 March 2019 04:34 CET Update -
article xml uploaded. 26 March 2019 04:34 CET Update https://www.mdpi.com/2072-6694/11/3/381/xml
article pdf uploaded. 26 March 2019 04:34 CET Updated version of record https://www.mdpi.com/2072-6694/11/3/381/pdf
article html file updated 26 March 2019 04:35 CET Original file -
article html file updated 4 April 2019 15:29 CEST Update -
article html file updated 9 April 2019 17:58 CEST Update -
article html file updated 11 April 2019 20:29 CEST Update -
article html file updated 26 April 2019 01:29 CEST Update -
article html file updated 16 October 2019 19:15 CEST Update -
article html file updated 11 February 2020 23:03 CET Update https://www.mdpi.com/2072-6694/11/3/381/html
Back to TopTop